Vertex topped fourth-quarter expectations and reported positive results for its next-generation cystic fibrosis drug. VRTX stock rose.
Vertex’s Next-Gen Cystic Fibrosis Drug Scores Big; Shares Rise On Quarterly Beat
Feb 6, 2024
![vertex’s-next-gen-cystic-fibrosis-drug-scores-big;-shares-rise-on-quarterly-beat](https://10xwealthreport.com/wp-content/uploads/2024/02/1539-vertexs-next-gen-cystic-fibrosis-drug-scores-big-shares-rise-on-quarterly-beat.jpg)